Kucsera, Dániel
Ruppert, Mihály
Sayour, Nabil V.
Tóth, Viktória E.
Kovács, Tamás
Hegedűs, Zsombor I.
Onódi, Zsófia
Fábián, Alexandra
Kovács, Attila
Radovits, Tamás
Merkely, Béla
Pacher, Pál
Ferdinandy, Péter
Varga, Zoltán V. http://orcid.org/0000-0002-2758-0784
Funding for this research was provided by:
HORIZON EUROPE Framework Programme (739593)
Momentum Research Grant (LP-2021-14)
National Heart Program (NVKP_16-1-2016-0017)
TKP/ITM/NKFIH
National Research, Development and Innovation Office of Hungary (OTKA-FK-134751, K134939)
New National Excellence Program (ÚNKP-21-3-II)
‘Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése’ (EFOP-3.6.3.-VEKOP-16-2017-00009, EFOP-3.6.3.-VEKOP-16-2017-00009)
Gedeon Richter Excellence PhD Scholarship (RRF-2.3.1-21-2022-00003)
Intramural Research Program (NIAAA)
Semmelweis University
Article History
Received: 18 December 2023
Accepted: 20 March 2024
First Online: 17 April 2024
Declarations
:
: P.F. is the founder and CEO of Pharmahungary, a group of R&D companies. A.F. and A.K. report personal fees from Argus Cognitive, Inc., outside the submitted work. All other authors declare no competing interests.